Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
Financial PostOctober 12, 2026
New method of use patent covering pelareorep as an immunotherapy for cancer has been issued in several countries, with U.S. issuance expected in the near term Three patent applications are pending, including two method of use with one expected to be converted…
Where this sits on TrendsMap
This story hasn’t been tied to a specific state or province yet — it sits in our Canada coverage. We hold 2111 politics stories in total, and 1248 from Financial Post.
This is a summary of reporting by Financial Post. Read the full story at the source.
Read full storyPredictions (0)
No predictions yet on this story — be the first to start one.
Comments (0)
GU
posting as a guest
Create a free account to comment under your own name and earn Pulse.